How much did Dynocardia raise?

Dynocardia raised $1.5 Million in a Seed round on March 24, 2023.

Who are the decision-makers at Dynocardia?

Fundz holds 2 contacts at Dynocardia, including the Chief Product Officer. Names and contact details are shown to Fundz members.

Dynocardia reported raising $1.5 Million in an initial SEC Form D filing, from an offering of $6 Million

PRIVATEApr 03, 2023$1.5M of $6M raised

Amount Raised

$1.5 Million

$1.5 Million sold, per SEC Form D (first sale Mar 24, 2023)

Round Type

Seed

CambridgeHealthcareHealth Care

Quick answer

Dynocardia raised $1.5 Million in a Seed round, dated March 24, 2023. Dynocardia is based in Cambridge, Massachusetts, United States.

How much did Dynocardia raise?: Dynocardia raised $1.5 Million in a Seed round on March 24, 2023.
What does Dynocardia do?: Dynocardia is a biomedical device development company committed to satisfying critical unmet needs to improve healthcare worldwide.
Where is Dynocardia based and how big is it?: Dynocardia is based in Cambridge, Massachusetts, United States.
Who are the decision-makers at Dynocardia?: Fundz holds 2 contacts at Dynocardia, including the Chief Product Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as Dynocardia that raised within 45 days of this round, from Fundz verified event records.

Jaguar Health raised $1.9M (Seed) on May 8, 2023.
Jaguar Health raised $1.8M (Seed) on May 8, 2023.
Aware Recovery Care raised $25M on May 8, 2023.
Optimize Systems raised $6M on May 4, 2023.
MiCare Path raised $1.2M (Seed) on May 4, 2023.
Embr Labs, Inc raised $35M (Funding Round) on May 3, 2023.

Who to call at Dynocardia, and when

A new round usually means Dynocardia is about to hire and buy. The teams that reach out first get the meeting.

An alert the day Dynocardia raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Dynocardia, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Dynocardia. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Dynocardia

Location

1188 CENTER STREET

Cambridge, Massachusetts, United States

About

Dynocardia is a biomedical device development company committed to satisfying critical unmet needs to improve healthcare worldwide. ViTrack™, our lead diagnostic device, is powered our proprietary technology making it the only stand-alone, cuff-less device that allows for continuous, non-invasive blood pressure (cNIBP) measurement. Unlike conventional occlusive devices, ViTrack offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable, mobile, and easy to use, with the accuracy of intra-arterial lines. ViTrack, with data-rich capability that includes heart rate, heart rhythm, and respiratory parameters in addition to blood pressure, enables early intervention prior to acute events.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Dynocardia raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

2 contacts

Verified contactsJose W., Chief Product Officer hiddenSee plans and pricing

Predictive Intelligence

Strategic

ML-powered predictions for Dynocardia's next move

See what Strategic adds

Dynocardia raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a sales rep uses this Or see plans and pricing →

5 screens from a live account. No signup.